GINGER WILLE: Open Payments
NPI 1396508990 · BERLIN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$640 in 21 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $443 · 2025 $640
Food & beverage: $640
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $250 |
| Phathom Pharmaceuticals, Inc. | 4 | $68 |
| ABBVIE INC. | 3 | $61 |
| Lilly USA, LLC | 3 | $54 |
| Merck Sharp & Dohme LLC | 2 | $50 |
| Aimmune Therapeutics, Inc. | 1 | $34 |
| PFIZER INC. | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Alexion Pharmaceuticals, Inc. | 1 | $21 |
| Exact Sciences Corporation | 1 | $19 |
Products named: EVENITY, REPATHA, VOQUEZNA, GARDASIL 9, UBRELVY, VOWST, PREVNAR 20, GEMTESA.
Industry payments across MD — which companies pay providers there.
